La perspectiva de Salud Pública (Parte 2)

Guía para el control de Enterobacterias resistentes al carbapenem II

Revisión del papel de las autoridades de salud pública en el control de las Enterobacteriaceae resistentes a carbapanem (CRE).

Fuente: CDC National Center for Emerging and Zoonotic Infectious Diseases

Indice
1. Referencias
2. Artículo

Referencias seleccionadas

  1. Ben-David D, Maor Y, Keller N, et al. Potential role of active surveillance in the controlof a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.Infect Control Hosp Epidemiol 2010 Jun;31(6):620-6.

  2. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Twenty Second Informational Supplement(January 2012). CLSI document M100-S22. Wayne, Pennsylvania, 2012.
     
  3. Kochar S, Sheard T, Sharma R, et al. Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2009 May;30(5):447-52.
     
  4. Munoz-Price LS, De La Cuesta C, Adams S, et al. Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida. Infect Control Hosp Epidemiol 2010 Oct;31(10):1074-7.
     
  5. Munoz-Price LS, Hayden MK, Lolans K, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae at a long-term acute care hospital. Infect Control Hosp Epidemiol 2010 Apr;31(4):341-7.
     
  6. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant enterococcusin health care facilities in a region. N Engl J Med 2001;344(19):1427-33.
     
  7. Schechner V, Kotlovsky T, Tarabeia J, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 2011 May;32(5):497-503.
     
  8. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008 Dec;29(12):1099-106.
     
  9. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008 Mar;52(3):1028-33.
     
  10. Schwaber MJ, Lev B, Israeli A, et al. Containment of a Country-wide Outbreakof Carbapenem-resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention. Clin Infect Dis 2011 Feb 11.